Initial treatment of prostatic cancer by endocrine measures and cytotoxic drugs.
Tunn
U W
UW
Urologische Klinik der Städtischen Kliniken Offenbach, Universität Frankfurt/Main, West-Germany.
Goldschmidt
A J
AJ
Peter
K
K
Becker
M
M
D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003534:Cyproterone / Q000008:administration & dosage / Q000031:analogs & derivatives; D017373:Cyproterone Acetate; D004054:Diethylstilbestrol / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D015996:Survival Rate
D000970:Antineoplastic Agents; D017373:Cyproterone Acetate; D004054:Diethylstilbestrol; D003520:Cyclophosphamide; D003534:Cyproterone; D005472:Fluorouracil